Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Chemomab Therapeutics Ltd DRC

Current price
0.59 USD -0.1 USD (-14.92%)
Last closed 0.66 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 10 518 580 USD
Yield for 12 month -64.46 %
21.11.2021 - 28.11.2021

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody had completed Phase 2a clinical trials that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel. Address: Building 7, Tel Aviv, Israel, 6158002

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price


P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-66 827 USD

Last Year

-57 773 USD

Current Quarter

-16 173 USD

Last Quarter

-18 938 USD

Key Figures CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 392 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -48.8 %
PEG Ratio
Return On Equity TTM -91.02 %
Wall Street Target Price 7 USD
Revenue TTM
Book Value 1.2 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.06 USD
Diluted Eps TTM -2.06 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CMMB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:16
Payout Ratio
Last Split Date 17.03.2021
Dividend Date

Stock Valuation CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 13.0039
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.3331
Price Book MRQ 0.6433

Financials CMMB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CMMB

For 52 weeks

0.42 USD 1.89 USD
50 Day MA 0.72 USD
Shares Short Prior Month 194 154
200 Day MA 0.83 USD
Short Ratio 2.14
Shares Short 221 869
Short Percent 1.65 %

Dynamics of changes in the value of assets




411.84 USD Microsoft Corporation -5.76 (-1.38%)
Detailed analytics

ETF funds



208.40 CHF iShares MDAX UCITS ETF (DE) -12.16 (-5.06%)
Detailed analytics



2205.6 USD Gold +35.66 (+1.64%)
Detailed analytics